Rectal Prolapse

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Novo Nordisk
Novo NordiskBAGSVAERD DENMARK, Denmark
1 program
The Nordic Rectal Prolapse StudyN/A1 trial
Active Trials
NCT05569980Enrolling By Invitation430Est. May 2027
Olympus
OlympusPA - Center Valley
1 program
endoluminal rectal prolapse repair under sedationN/A1 trial
Active Trials
NCT01980043Completed10Est. Mar 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Novo NordiskThe Nordic Rectal Prolapse Study
Olympusendoluminal rectal prolapse repair under sedation

Clinical Trials (2)

Total enrollment: 440 patients across 2 trials

NCT05569980Novo NordiskThe Nordic Rectal Prolapse Study

The Nordic Rectal Prolapse Study

Start: Apr 2023Est. completion: May 2027430 patients
N/AEnrolling By Invitation
NCT01980043Olympusendoluminal rectal prolapse repair under sedation

Endoluminal and Needlescopic Assisted Repair of Rectal Prolapse

Start: May 2013Est. completion: Mar 201810 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space